LevelJump Announces That It Will Be Delayed in Filing Year-End Reporting Documents
LevelJump Announces That It Will Be Delayed in Filing Year-End Reporting Documents
Toronto, Ontario--(Newsfile Corp. - April 15, 2024) - LevelJump Healthcare Corp. (TSXV: JUMP) ("LevelJump" or the "Company") announces today that it anticipates the filing of its annual financial statements, management's discussion and analysis and related officer certifications for the financial year ended December 31, 2023 (collectively, the "Annual Filings") will be delayed beyond the required filing deadline under Parts 4 and 5 of National Instrument 51-102 - Continuous Disclosure Obligations and pursuant to National Instrument 52-109 - Certification of Disclosure in Issuer's Annual and Interim Filings, being April 29, 2024 (the "Filing Deadline").
安大略省多倫多--(Newsfile Corp.-2024 年 4 月 15 日)- LevelJump 醫療保健公司(多倫多證券交易所股票代碼:JUMP)(“LevelJump” 或 “公司”) 今天宣佈,預計截至2023年12月31日的財政年度的年度財務報表、管理層的討論和分析以及相關官員認證(統稱 “年度申報”)的提交將推遲到國家儀器51-102——持續披露義務第4和5部分規定的申報截止日期,以及根據國家儀器52-109——發行人年度和中期申報的披露證明,即2024年4月29日(“申報”)截止日期”)。
In light of a recent change in the Company's auditor to Kreston GTA LLP (see the Company's Notice of Change of Auditors filed on SEDAR+ dated March 19, 2024) and an exceptionally large amount of audit work related to the Company's Alberta acquisitions during the 4th quarter (see the Company's news release dated October 11, 2023), the Company has determined that it will not be able to complete the audit and file the Annual Filings by the Filing Deadline. The Company intends to work closely with its auditor and expects to file the Annual Filings as soon as possible, and in any event no later than June 28, 2024.
鑑於公司核數師最近變更爲Kreston GTA LLP(見公司於2024年3月19日在SEDAR+上提交的審計員變更通知),以及與公司在第四季度收購艾伯塔省相關的大量審計工作第四 季度(見公司2023年10月11日的新聞稿),公司已確定無法在申報截止日期之前完成審計和提交年度申報。該公司打算與其核數師密切合作,並希望儘快提交年度申報,無論如何都不遲於2024年6月28日。
The Company is providing this default announcement in accordance with National Policy 12-203 - Management Cease Trade Orders ("NP 12-203"). The Company has made an application to the Ontario Securities Commission, as principal regulator of the Company, for a management cease trade order ("MCTO") under NP 12-203 in respect of the anticipated default regarding the Annual Filings. The granting of the MCTO is at the discretion of the Ontario Securities Commission. The issuance of the MCTO generally will not affect the ability of persons who have not been directors, officers or insiders of the Company to trade in their securities. In the event that the MCTO is granted, it will be in effect until the default is remedied.
公司根據國家政策12-203——管理層停止交易令(“NP 12-203”)發佈此默認公告。該公司已向作爲公司主要監管機構的安大略省證券委員會申請根據NP 12-203發佈管理停止交易令(“MCTO”),內容涉及年度申報的預期違約情況。MCTO的授予由安大略省證券委員會自行決定。MCTO的發行通常不會影響非公司董事、高級管理人員或內部人士交易其證券的能力。如果授予 MCTO,它將一直有效,直到默認值得到糾正。
The Company intends to follow the provisions of the Alternative Information Guidelines set out in NP 12-203, including the issuance of bi-weekly default status reports in the form of news releases, for as long as the Company remains in default. The Company confirms as of the date of this news release that there is no insolvency proceeding against it and there is no other material information concerning the affairs of the Company that has not been generally disclosed.
只要公司繼續違約,公司就打算遵守NP 12-203中規定的替代信息指南的規定,包括以新聞稿的形式每兩週發佈違約狀態報告。截至本新聞稿發佈之日,公司確認沒有對其進行破產程序,也沒有其他未被普遍披露的有關公司事務的重大信息。
About LevelJump Healthcare
關於 LevelJump
LevelJump Healthcare Corp., (TSXV: JUMP) provides telehealth solutions to client hospitals and imaging centers through its Teleradiology division, as well as in person radiology services through its Diagnostic Centres. JUMP focuses primarily on critical care for urgent and emergency patients, establishing integral relationships in the communities we serve.
LevelJump Healthcare Corp.(多倫多證券交易所股票代碼:JUMP)通過其遠程放射學部門爲客戶醫院和成像中心提供遠程醫療解決方案,並通過其診斷中心提供面對面的放射學服務。JUMP主要專注於急診和急診患者的重症監護,在我們服務的社區中建立完整的關係。
ON BEHALF OF THE BOARD OF DIRECTORS OF
LEVELJUMP HEALTHCARE CORP.
代表董事會
LEVELJUMP 醫療保健公司
Mitchell Geisler
Chief Executive Officer
米切爾·蓋斯勒
首席執行官
Caitlin-Robyn Densmore
Business Development Manager
Caitlin.Densmore@leveljumphealthcare.com
(437) 214-1568
Caitlin-Robyn Densmore
業務發展經理
Caitlin.Densmore@leveljumphealthcare.com
(437) 214-1568
CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION
關於前瞻性信息的警示聲明
This news release contains "forward-looking information" within the meaning of applicable securities laws relating to the Company's business plans and the outlook of the Company's industry. Although the Company believes, in light of the experience of its officers and directors, current conditions and expected future developments and other factors that have been considered appropriate, that the expectations reflected in this forward-looking information are reasonable, undue reliance should not be placed on them because the Company can give no assurance that they will prove to be correct. Actual results and developments may differ materially from those contemplated by these statements. The statements in this press release are made as of the date of this release and the Company assumes no responsibility to update them or revise them to reflect new events or circumstances other than as required by applicable securities laws. The Company undertakes no obligation to comment on analyses, expectations or statements made by third-parties in respect of the Company, Canadian Teleradiology Services, Inc., their securities, or their respective financial or operating results (as applicable).
本新聞稿包含與公司業務計劃和公司行業前景有關的適用證券法所指的 “前瞻性信息”。儘管根據其高管和董事的經驗、當前狀況和預期的未來發展以及其他被認爲適當的因素,公司認爲,這些前瞻性信息中反映的預期是合理的,但不應過度依賴這些期望,因爲公司無法保證這些預期會被證明是正確的。實際結果和發展可能與這些陳述所設想的結果和進展存在重大差異。本新聞稿中的聲明自本新聞稿發佈之日起作出,除適用的證券法要求外,公司不承擔任何責任對其進行更新或修改以反映新的事件或情況。公司沒有義務評論第三方對公司、Canadian Teleradiology Services, Inc.、其證券或各自的財務或經營業績(如適用)的分析、預期或聲明。
Neither the Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Exchange) accepts responsibility for the adequacy or accuracy of this release.
交易所及其監管服務提供商(該術語在聯交所政策中定義)均不對本新聞稿的充分性或準確性承擔責任。
The securities being offered have not been, and will not be, registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act") or any U.S. state securities laws, and may not be offered or sold in the United States or to, or for the account or benefit of, United States persons absent registration or an applicable exemption from the registration requirements of the U.S. Securities Act and applicable U.S. state securities laws. This press release does not constitute an offer to sell or the solicitation of an offer to buy securities in the United States, nor in any other jurisdiction.
所發行的證券過去和將來都沒有根據經修訂的1933年《美國證券法》(“美國證券法”)或任何美國州證券法進行註冊,也不得在美國發行或出售,也不得向未經註冊或適用《美國證券法》和適用的美國州證券法註冊要求豁免的美國人發行或出售,也不得爲美國人的賬戶或利益進行發行或出售。本新聞稿不構成在美國或任何其他司法管轄區出售證券的要約或要求購買證券的要約。
譯文內容由第三人軟體翻譯。